Todd Asset Management LLC Has $21.16 Million Position in DaVita Inc. $DVA

Todd Asset Management LLC lifted its stake in shares of DaVita Inc. (NYSE:DVA) by 13.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 186,274 shares of the company’s stock after acquiring an additional 21,887 shares during the period. Todd Asset Management LLC’s holdings in DaVita were worth $21,163,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. National Pension Service acquired a new position in shares of DaVita during the 3rd quarter valued at $1,305,000. Doma Perpetual Capital Management LLC lifted its position in shares of DaVita by 23.3% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 355,574 shares of the company’s stock valued at $47,245,000 after acquiring an additional 67,214 shares during the period. Intech Investment Management LLC lifted its position in shares of DaVita by 122.4% during the 3rd quarter. Intech Investment Management LLC now owns 27,441 shares of the company’s stock valued at $3,646,000 after acquiring an additional 15,104 shares during the period. Nordea Investment Management AB lifted its position in shares of DaVita by 18.0% during the 4th quarter. Nordea Investment Management AB now owns 338,192 shares of the company’s stock valued at $38,321,000 after acquiring an additional 51,607 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in DaVita by 175.1% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,409 shares of the company’s stock worth $2,446,000 after buying an additional 11,718 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Activity at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. This represents a 27.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

DaVita Trading Down 0.1%

DVA opened at $198.39 on Monday. The company’s fifty day moving average price is $162.93 and its two-hundred day moving average price is $138.27. The company has a market cap of $12.74 billion, a price-to-earnings ratio of 18.40, a PEG ratio of 0.65 and a beta of 0.84. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $202.69.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.33 by $0.54. The company had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. Zacks Research upgraded shares of DaVita from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. UBS Group upped their price objective on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Barclays upped their price objective on shares of DaVita from $158.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Finally, Truist Financial upped their price objective on shares of DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $199.17.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.